List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=4
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 767,
    "next": "http://api.gregory-ms.com/trials/?page=5",
    "previous": "http://api.gregory-ms.com/trials/?page=3",
    "results": [
        {
            "trial_id": 400302,
            "title": "Multi-center, Randomized, Double-blind, Parallel-group, Double-dummy, Active-controlled, Comparative Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ponesimod Vers...",
            "summary": "<p>EudraCT Number: 2020-004431-24<br />Sponsor Protocol Number: 67896153MSC3001<br />Sponsor Name: Janssen-Cilag International NV<br />Start Date: 2022-09-30<br />Medical condition: Relapsing-remitting Multiple Sclerosis<br />Disease: <br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Children, Adolescents, Under 18<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-004431-24/SE\">SE</a> (Ongoing)</p>",
            "published_date": null,
            "discovery_date": "2022-10-13T06:40:18.064662Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004431-24",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 399851,
            "title": "Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®",
            "summary": "<b>Condition</b>:    Multiple Sclerosis (MS)<br /><b>Interventions</b>:    Other: Neurostatus-SMARTCARE;   Other: Standard Neurostatus-EDSS<br /><b>Sponsors</b>:    University Hospital, Basel, Switzerland;   Novartis Pharma AG, Basel, Switzerland<br /><b>Not yet recruiting</b>",
            "published_date": "2022-10-11T12:00:00Z",
            "discovery_date": "2022-10-12T12:05:13.557013Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05575843?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 397230,
            "title": "Effect of Arm Ergometer Exercise Training on Upper Extremity Function in People With Multiple Sclerosis.",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: exercise<br /><b>Sponsor</b>:    Dokuz Eylul University<br /><b>Not yet recruiting</b>",
            "published_date": "2022-10-07T12:00:00Z",
            "discovery_date": "2022-10-07T13:05:19.200393Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05571631?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 397229,
            "title": "Effectiveness of Telerehabilitation Interventions in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Behavioral: telerehabilitation<br /><b>Sponsor</b>:    Dokuz Eylul University<br /><b>Recruiting</b>",
            "published_date": "2022-10-07T12:00:00Z",
            "discovery_date": "2022-10-07T13:05:19.193478Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05571826?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 395367,
            "title": "Study Evaluating Kesimpta® Treatment Effects and Patient Reported Outcomes in Patients With Relapsing Multiple Sclerosis Transitioning From Other Disease Modifying Therapies",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Ofatumumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>",
            "published_date": "2022-10-04T12:00:00Z",
            "discovery_date": "2022-10-04T12:35:16.781424Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05566756?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 394699,
            "title": "\"Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis\"",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Ataxia;   Paraplegia<br /><b>Intervention</b>:    Device: Atalante<br /><b>Sponsor</b>:    Multiple Sclerosis Center of Catalonia<br /><b>Recruiting</b>",
            "published_date": "2022-10-03T12:00:00Z",
            "discovery_date": "2022-10-03T13:45:16.832507Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05563402?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 392448,
            "title": "Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers",
            "summary": "<b>Condition</b>:    Multiple Sclerosis, Vocal Biomarkers, Non Motor Symptoms<br /><b>Intervention</b>:    Other: Voice analysis<br /><b>Sponsors</b>:    University Hospital Inselspital, Berne;   AUDEERING GMBH<br /><b>Recruiting</b>",
            "published_date": "2022-09-30T12:00:00Z",
            "discovery_date": "2022-09-30T12:40:12.831847Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05561621?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 392446,
            "title": "Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Spasticity, Muscle;   Pain, Chronic<br /><b>Interventions</b>:    Device: FlowOx 2.0;   Device: FlowOx2.0 (Sham)<br /><b>Sponsor</b>:    Otivio AS<br /><b>Not yet recruiting</b>",
            "published_date": "2022-09-30T12:00:00Z",
            "discovery_date": "2022-09-30T12:40:12.826069Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05562453?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 392445,
            "title": "Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis: A Pilot Study.",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis, Chronic Progressive;   High-Intensity Interval Training;   Motor Symptoms<br /><b>Interventions</b>:    Behavioral: HIIT;   Behavioral: MCT<br /><b>Sponsor</b>:    Klinik Valens<br /><b>Recruiting</b>",
            "published_date": "2022-09-30T12:00:00Z",
            "discovery_date": "2022-09-30T12:40:12.823145Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05562414?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 391648,
            "title": "The Effect of Transcranial Direct Current Stimulation on Fatigue Among Multiple Sclerosis Patients.Patients",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Device: a-tDCS<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>",
            "published_date": "2022-09-29T12:00:00Z",
            "discovery_date": "2022-09-29T12:35:19.146318Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05560139?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        }
    ]
}